APA (7th ed.) Citation

CA, B., A, Z., S, R., JO, M., M, E., R, M., . . . E, T. (2021). LDL-Based Lipid Nanoparticle Derived for Blood Plasma Accumulates Preferentially in Atherosclerotic Plaque. Frontiers in bioengineering and biotechnology, 9, 794676. https://doi.org/10.3389/fbioe.2021.794676

Chicago Style (17th ed.) Citation

CA, Boada, et al. "LDL-Based Lipid Nanoparticle Derived for Blood Plasma Accumulates Preferentially in Atherosclerotic Plaque." Frontiers in Bioengineering and Biotechnology 9 (2021): 794676. https://doi.org/10.3389/fbioe.2021.794676.

MLA (9th ed.) Citation

CA, Boada, et al. "LDL-Based Lipid Nanoparticle Derived for Blood Plasma Accumulates Preferentially in Atherosclerotic Plaque." Frontiers in Bioengineering and Biotechnology, vol. 9, 2021, p. 794676, https://doi.org/10.3389/fbioe.2021.794676.